Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cardiovascular diseases | D002318 | HP_0001626 | — | — | 1 | 1 | 1 | 1 | 4 |
Covid-19 | D000086382 | — | — | — | 1 | — | 1 | — | 2 |
Post-acute covid-19 syndrome | D000094024 | — | — | — | 1 | — | 1 | — | 2 |
Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | — | — | — | 1 | — | 1 |
Overweight | D050177 | — | E66.3 | — | — | — | 1 | — | 1 |
Pelvic floor disorders | D059952 | — | — | — | — | — | 1 | — | 1 |
Sepsis | D018805 | HP_0100806 | A41.9 | — | — | — | 1 | — | 1 |
Toxemia | D014115 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Prostatic neoplasms | D011471 | — | C61 | 2 | 8 | 1 | — | 2 | 11 |
Osteoporosis | D010024 | HP_0000939 | M81.0 | 1 | 2 | 2 | — | 3 | 7 |
Menopause | D008593 | EFO_0003922 | N95 | — | 3 | 2 | — | 3 | 7 |
Syndrome | D013577 | — | — | 1 | 2 | 2 | — | 1 | 4 |
Metabolic bone diseases | D001851 | HP_0000938 | — | 1 | 1 | 1 | — | 2 | 4 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | 2 | 2 | — | 1 | 3 |
Coronary disease | D003327 | — | — | — | 2 | 1 | — | — | 2 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | 2 | 1 | — | — | 2 |
Meningitis | D008581 | HP_0001287 | G03 | — | — | 1 | — | — | 1 |
Coronary artery disease | D003324 | — | I25.1 | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 3 | — | — | 1 | 5 |
Neoplasms | D009369 | — | C80 | 3 | 3 | — | — | — | 4 |
Non-small-cell lung carcinoma | D002289 | — | — | 2 | 2 | — | — | — | 2 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 2 | 2 | — | — | — | 2 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | 2 | — | — | — | 2 |
Leukemia | D007938 | — | C95 | 1 | 1 | — | — | — | 2 |
Lymphoid leukemia | D007945 | — | C91 | 1 | 1 | — | — | — | 2 |
Adenocarcinoma | D000230 | — | — | 1 | 2 | — | — | — | 2 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | 1 | — | — | — | 2 |
Lymphoma | D008223 | — | C85.9 | 1 | 1 | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Infections | D007239 | EFO_0000544 | — | 2 | — | — | — | — | 2 |
Hiv infections | D015658 | EFO_0000764 | B20 | 2 | — | — | — | — | 2 |
Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 2 | — | — | — | — | 2 |
Radiation injuries | D011832 | — | — | 2 | — | — | — | — | 2 |
Acute radiation syndrome | D054508 | — | — | 2 | — | — | — | — | 2 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | 1 | — | — | — | — | 1 |
Head and neck neoplasms | D006258 | — | — | 1 | — | — | — | — | 1 |
Endometrial neoplasms | D016889 | EFO_0004230 | — | 1 | — | — | — | — | 1 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 3 | 3 |
Insulin resistance | D007333 | HP_0000855 | — | — | — | — | — | 2 | 2 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | — | 2 | 2 |
Healthy volunteers/patients | — | — | — | — | — | — | — | 2 | 2 |
Diet therapy | D004035 | — | — | — | — | — | — | 1 | 1 |
Weight loss | D015431 | HP_0001824 | — | — | — | — | — | 1 | 1 |
Blood pressure | D001794 | EFO_0004325 | — | — | — | — | — | 1 | 1 |
Male breast neoplasms | D018567 | — | — | — | — | — | — | 1 | 1 |
Disease progression | D018450 | — | — | — | — | — | — | 1 | 1 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | — | — | — | — | 1 | 1 |
Drug common name | Genistein |
INN | genistein |
Description | Genistein is a 7-hydroxyisoflavone with additional hydroxy groups at positions 5 and 4'. It is a phytoestrogenic isoflavone with antioxidant properties. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, a phytoestrogen, a plant metabolite, a geroprotector and a human urinary metabolite. It is a conjugate acid of a genistein(1-). |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12 |
PDB | — |
CAS-ID | 446-72-0 |
RxCUI | — |
ChEMBL ID | CHEMBL44 |
ChEBI ID | 28088 |
PubChem CID | 5280961 |
DrugBank | DB01645 |
UNII ID | DH2M523P0H (ChemIDplus, GSRS) |